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Abstract Although insulin secretion is usually regarded as a
Ca2+-dependent mechanism, recent studies have suggested the
existence of a Ca2+-independent pathway of regulation by
glucose. Here, mouse islets were used to compare the contribu-
tion of Ca2+-dependent and -independent pathways. Glucose
increased insulin release in a concentration-dependent manner
both in a control medium, when it depolarizes L cells and raises
[Ca2+]i (triggering signal), and in the presence of 30 mM K
+ and
diazoxide, when it does not further raise [Ca2+]i but increases its
efficacy on exocytosis. Both Ca2+-dependent responses were
amplified by glucagon-like peptide-1+acetylcholine, and were
strongly potentiated by forskolin+PMA. Under conditions of
mild or stringent Ca2+ deprivation, glucose had no effect either
alone or with GLP-1 and acetylcholine, and was poorly effective
even during pharmacological activation of protein kinases A and
C. Similar results were obtained with rat islets. It is concluded
that physiological regulation of insulin release by glucose is
essentially achieved through the two Ca2+-dependent pathways
without significant contribution of a Ca2+-independent mecha-
nism.
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1. Introduction
Pancreatic L cells are fuel-sensing cells under hormonal and
neural control [1^5]. This explains the complexity of the mech-
anisms regulating insulin secretion. Besides classical transduc-
tion pathways involved in the response to hormones and neu-
rotransmitters, sophisticated systems have evolved to couple
fuel detection to the generation of secretory signals. The stim-
ulation of insulin secretion by glucose requires metabolism of
the sugar by the L cell and involves at least two mechanisms.
The best characterized and major one serves to produce the
triggering signal of exocytosis, a rise in the cytoplasmic Ca2
concentration ([Ca2]i), through the following sequence of
events [6^9]. Glucose metabolism generates signals, among
which an increase in the ATP/ADP ratio [10], which close
ATP-sensitive K channels (K-ATP channels) in the plasma
membrane. This leads to depolarization, opening of voltage-
dependent Ca2 channels and acceleration of Ca2 in£ux. The
second mechanism has been identi¢ed during treatment of L
cells with diazoxide to hold K-ATP channels open, and high
K to depolarize the membrane and clamp [Ca2]i at an ele-
vated, stable level [11,12]. Under these conditions glucose was
found to increase the e⁄cacy of Ca2 on the secretory process
[13]. The existence of this second mechanism is now widely
accepted [14^16], but its mechanisms are still incompletely
understood.
Studies using permeabilized cells [17,18] and membrane ca-
pacitance measurements [19,20] have con¢rmed that Ca2 is a
triggering signal of exocytosis, but have also shown that exo-
cytosis can be induced in a Ca2-independent manner by
poorly hydrolyzable GTPQS [21^23]. Recent studies have re-
ported that glucose increases insulin release from intact rat
islets and insulin-secreting HIT cells incubated or perifused
under conditions of stringent Ca2 deprivation. The necessary
condition to disclose this e¡ect was a combined activation of
protein kinases A and C (PKA and PKC). These studies
prompted the provocative suggestion that glucose also regu-
lates insulin secretion by a third, Ca2-independent, mecha-
nism [24,25].
It is essential to evaluate the potential importance of such a
pathway of regulation of insulin secretion by glucose. We,
therefore, compared the e¡ects of various glucose concentra-
tions on insulin release from mouse and rat islets incubated
under selected conditions: in a control medium when the reg-
ulation is mainly dependent on the activity of K-ATP chan-
nels, in the presence of 30 mM K and diazoxide to test the
second mechanism of regulation, and under mild (diazoxide
and nimodipine) and stringent (no Ca2+EGTA) conditions
of Ca2 deprivation. Glucose was tested alone, during phys-
iological, receptor-mediated, activation of PKA and PKC
with glucagon-like peptide-1 and acetylcholine [26^28], and
during strong activation of the kinases with PMA (acting
directly on PKC) and forskolin (stimulating adenylyl cyclase).
2. Materials and methods
2.1. Preparation and solutions
Islets were isolated by collagenase digestion of the pancreas of fed
female NMRI mice (25^30 g) or fed female Wistar rats (200^250 g),
followed by hand-picking.
Three types of solutions were used. For islet isolation and for con-
trol preincubations and incubations, the medium was a bicarbonate-
bu¡ered solution that contained 120 mM NaCl, 4.8 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgCl2, and 24 mM NaHCO3. The high-K medium
contained 30 mM KCl and only 94.8 mM NaCl to maintain isoosmo-
larity. These solutions were supplemented with 250 WM diazoxide to
ensure optimal control of the membrane potential and permit the K-
ATP channel-independent e¡ect of glucose to be studied [13]. Ca2-
free solutions were prepared by replacing CaCl2 with MgCl2 and add-
ing 1 mM EGTA. All solutions were gassed with O2/CO2 (94:6) to
maintain pH 7.4, and contained bovine serum albumin (1 mg/ml).
After isolation the islets were subjected to two preincubations and a
¢nal incubation, all at 37‡C. The ¢rst preincubation of 30 min was
always carried out in control medium containing 15 mM glucose, and
served to recover from the isolation procedure. The islets were then
distributed in batches of three and transferred into glass tubes con-
taining 1 ml medium for a second preincubation of 60 min, in control
medium containing 3 mM glucose alone (A and B), in control medium
containing 3 mM glucose, 5 WM nimodipine and 250 WM diazoxide
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(C), or in Ca2-free medium containing 3 mM glucose alone (D). At
the end of this second preincubation, the medium was completely
removed, discarded, and replaced by 1 ml of medium for a ¢nal
incubation of 60 min. This medium, which contained various glucose
concentrations and was supplemented with test substances (PMA,
forskolin, acetylcholine, GLP-1), was a control medium (A), a high-
K medium (B), a control medium with nimodipine and diazoxide (C)
or a Ca2-free medium (D). This procedure avoided manipulation of
islets that become fragile after prolonged incubation in the absence of
Ca2. At the end of the incubation, a portion of the medium was
taken and appropriately diluted before insulin measurement by radio-
immunoassay with rat insulin as the standard (Novo Research Insti-
tute, Bagsvaerd, Denmark). In one series of experiments, the ¢nal
incubation medium was supplemented with sodium azide or adrena-
line.
2.2. Reagents
Diazoxide was obtained from Schering-Plough Avondale (Rath-
drum, Ireland); nimodipine from Bayer (Wuppertal, Germany); for-
skolin from Calbiochem (San Diego, CA); adrenaline from Parke-
Davis (Zaventem, Belgium); sodium azide from Merck A.G. (Darm-
stadt, Germany); EGTA, phorbol 12-myristate 13-acetate (PMA),
acetylcholine chloride (ACh) and 7^36 glucagon-like peptide-1 amide
(hereafter abbreviated GLP-1) from Sigma Chemical Co. (St. Louis,
MO).
2.3. Presentation of results
Results are presented as means þ S.E.M. for the indicated number
of batches of islets. The statistical signi¢cance of di¡erences between
means was assessed by analysis of variance, followed by a Newman-
Keuls test. Di¡erences were considered signi¢cant at P6 0.05.
3. Results
3.1. Experiments with mouse islets
Under control conditions (normal Ca2 and K), when the
regulation of insulin secretion primarily depends on K-ATP
channels, the stimulation by glucose displayed its character-
istic sigmoidal dose-response relationship (Fig. 1A). When 25
nM GLP-1 and 1 WM ACh were added to the medium to
activate PKA and PKC, basal release in the absence of glu-
cose was increased 2.5-fold (0.65 þ 0.10 vs. 0.26 þ 0.03 ng/islet/
h), the Km of the response was decreased from 16 to V11
mM, and the response to 30 mM glucose was doubled
(9.6 þ 0.6 vs. 4.8 þ 0.4 ng/islet/h). The combination of 1 WM
forskolin and 25 nM PMA similarly shifted the Km, but in-
creased basal and maximum responses 7-fold. The e¡ects of a
pharmacological activation of PKA and PKC are thus con-
siderably larger than those of the physiological agents (Fig.
1A).
When the L cell membrane is depolarized with 30 mM K
in the presence of diazoxide, the K-ATP channel independ-
ent, Ca2-dependent e¡ect of glucose can be studied [11^13].
Under these conditions, insulin release was markedly stimu-
lated even in the absence of glucose (3.8 þ 0.3 ng/islet/h), but
the sugar still caused a concentration-dependent increase in
secretion (KmV13 mM) (Fig. 1B). GLP-1 and ACh had no
e¡ect on high K-induced insulin secretion in the low range of
glucose concentrations, but produced a 30^40% potentiation
(P6 0.01) in the presence of 15^30 mM glucose. The combi-
nation of forskolin and PMA was much more potent, increas-
ing the response in the absence of glucose by 6.5-fold. How-
ever, a dose-dependent e¡ect of glucose persisted under these
conditions (Fig. 1B), which supports our previous conclusion
that the second pathway of glucose regulation of insulin re-
lease is not mediated by an activation of PKA and PKC [13].
Blockade of Ca2 in£ux through voltage-dependent Ca2
channels by nimodipine [29] and diazoxide [11] abrogated
glucose-induced insulin release (Fig. 1C). The low rate of se-
cretion was increased by GLP-1 and ACh (P6 0.05), but the
e¡ect of glucose was limited to a doubling (P6 0.05) between
7 and 15 mM glucose. At 15 mM glucose, insulin secretion
was 12-fold smaller than when Ca2 entry was not inhibited
(compare Figs. 1C and 1A). Again, the e¡ect of forskolin and
PMA was much larger than that of GLP-1 and ACh, and it
was augmented by 3 and 7 mM glucose. In fact, the secretion
rates were similar whether forskolin and PMA were tested in
the absence or presence of diazoxide and nimodipine in the
range 0^7 mM glucose, i.e. when Ca2 in£ux was not stimu-
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Fig. 1. Concentration dependence of the e¡ect of glucose on insulin
release by incubated mouse islets. Batches of three islets were prein-
cubated for 60 min in a control medium containing 3 mM glucose
alone (A and B) or supplemented with 5 WM nimodipine and 250
WM diazoxide (C), or in a Ca2-free medium containing 3 mM glu-
cose and 1 mM EGTA (D). At the end of this preincubation, the
medium was replaced by 1 ml of medium for a ¢nal incubation of
60 min. This medium, which contained various glucose concentra-
tions was a control medium (A), a high-K medium (B), a control
medium with 5 WM nimodipine and 250 WM diazoxide (C), or a
Ca2-free medium with 1 mM EGTA (D). As indicated, these me-
dia were also suplemented with 25 nM GLP-1 and 1 WM ACh (b),
or 1 WM forskolin (Fk) and 25 nM PMA (F). After 60 min of incu-
bation, an aliquot of the medium was taken for insulin assay. The
upper and lower panels C and D show the same curves at the same
scales as in A and B (upper panels) or at 10-fold larger scales (low-
er panels). Values are means þ S.E.M for 15^35 batches of islets
from 3^7 separate experiments.
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lated. In contrast, higher glucose concentrations had an e¡ect
only when Ca2 in£ux was not prevented (compare Figs. 1C
and 1A). These characteristics are best explained by a sensi-
tization of the releasing machinery to the action of Ca2.
Under conditions of stringent Ca2 deprivation (no
CaCl2+EGTA), glucose did not a¡ect insulin secretion either
alone or in the presence of GLP-1 and ACh (Fig. 1D). In a
glucose- and Ca2-free medium, forskolin and PMA approx-
imately doubled secretion, as they did in the presence of Ca2
without (Fig. 1A) or with diazoxide and nimodipine (Fig. 1C).
In contrast, glucose was now without additional e¡ect. At 15
mM glucose, insulin secretion was only 7% of that measured
under control conditions (compare Figs. 1D and 1A).
To ascertain that insulin secretion observed in the absence
of Ca2 did not re£ect unspeci¢c leakage from damaged cells,
we compared the inhibitory e¡ects of energy deprivation and
K2-adrenoceptor activation under these four conditions. When
azide, a mitochondrial poison, was used at the high concen-
tration of 5 mM, insulin release was consistently blocked
(Table 1). With 1 mM azide, however, the inhibition was
strong when glucose was used alone, less in the presence of
high K and non-existent when forskolin and PMA were used
in the absence of Ca2 in£ux (diazoxide+nimodipine or Ca2-
free medium). A low concentration of adrenaline (10 nM)
inhibited insulin secretion by 20^40% under all conditions,
and a high concentration (10 WM) consistently abolished in-
sulin secretion (Table 1). These results show that regulated
pathways underlie insulin release even when it is stimulated
by forskolin and PMA under stringent Ca2 deprivation [24].
It is also clear that physiological release induced by glucose in
a control medium is the most sensitive to di¡erent physiolog-
ical potentiators (GLP-1 and ACh) and inhibitors (adrenaline)
as well as to energy deprivation.
3.2. Experiments with rat islets
As rat islets were used in the original study on which the
description of the novel pathway for glucose regulation is
based [24], a series of experiments was also performed with
this model. Under control conditions, glucose increased insu-
lin secretion in a concentration-dependent manner, to a max-
imum of about 20-fold. This stimulation was potentiated 4^5-
fold by 1 WM forskolin and 25 nM PMA (Fig. 2A). In the
absence of Ca2, insulin secretion was highest in the absence
of glucose (0.73 þ 0.06 ng/islet/h) and decreased by about 40%
when the concentration of the sugar was raised (P6 0.05 at
7 mM glucose). When the medium was supplemented with
1 WM forskolin and 25 nM PMA, the rate of secretion re-
mained similar between 0 and 30 mM glucose. At 15 mM
glucose, insulin secretion was only 8% of that measured under
control conditions (compare Figs. 2D and 2A). When forsko-
lin and PMA were used at higher concentrations of 10 WM
and 100 nM respectively, insulin secretion was doubled be-
tween 0 and 10 mM glucose, and then plateaued (Fig. 2D).
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Fig. 2. Concentration dependence of the e¡ect of glucose on insulin
release by incubated rat islets. Batches of three islets were preincu-
bated for 60 min in a control medium containing 3 mM glucose (A)
or in a Ca2-free medium containing 3 mM glucose and 1 mM
EGTA (D). At the end of this preincubation, the medium was re-
placed by 1 ml of medium for a ¢nal incubation of 60 min. This
medium, which contained various glucose concentrations, was a
control medium (A) or a Ca2-free medium (D). It was supple-
mented with forskolin (Fk) and PMA at the indicated concentra-
tions. After 60 min of incubation, an aliquot of the medium was
taken for insulin assay. The two panels D show the same curves at
the same scale as in A (upper panel) or at a 10-fold larger scale
(lower panel). Values are means þ S.E.M for 15^30 batches of islets
from 3^6 separate experiments.
Table 1
E¡ects of sodium azide and adrenaline on insulin release from mouse islets stimulated by 15 mM glucose under di¡erent conditions
Incubation conditions (mM) Insulin release (ng/islet/60 min or percentage of controls)
Ca2 K Others Controls Sodium azide Adrenaline
1 mM 5 mM 10 nM 10 WM
2.5 4.8 ^ 3.1 þ 0.2 0.8 þ 0.1 0.2 þ 0.1 1.6 þ 0.2 0.2 þ 0.1
(26 þ 3%) (5 þ 1%) (57 þ 9%) (9 þ 2%)
2.5 30 Dz 8.8 þ 0.6 4.3 þ 0.3 0.3 þ 0.1 7.2 þ 0.5 0.9 þ 0.2
(49 þ 3%) (3 þ 1%) (81 þ 5%) (9 þ 2%)
2.5 4.8 Dz+Nimo 4.5 þ 0.4 4.2 þ 0.3a 0.3 þ 0.1 3.6 þ 0.4 0.3 þ 0.1
PMA+Fk (98 þ 7%) (6 þ 1%) (82 þ 8%) (5 þ 2%)
0 4.8 PMA+Fk 1.8 þ 0.1 1.7 þ 0.1a 0.3 þ 0.1 1.0 þ 0.1 0.4 þ 0.1
(100 þ 8%) (17 þ 4%) (61 þ 7%) (22 þ 3%)
The concentration of glucose was 15 mM and test substances were present at the following concentrations: Dz (diazoxide) 250 WM, Nimo
(nimodipine) 5 WM, PMA 25 nM, Fk (forskolin) 1 WM. EGTA (1 mM) was added to the medium without Ca2. Values are means þ S.E.M for
20 batches of islets (1 mM azide and 10 nM adrenaline) or 10 batches of islets (5 mM azide and 10 WM adrenaline). The percentage of change was
calculated relative to controls within the same experiments. aNot signi¢cantly di¡erent from controls.
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Very strong stimulation of PKA and PKC was thus necessary
for glucose to increase insulin release in the absence of Ca2,
and this small e¡ect was restricted to low concentrations of
the sugar as previously reported [24].
4. Discussion
The present study evaluated whether a Ca2-independent
pathway [24,25] might signi¢cantly contribute to the regula-
tion of insulin secretion by glucose. In rat islets, glucose pro-
duced an 18-fold increase in insulin secretion whether the
control medium contained or not 1 WM forskolin and 25
nM PMA, but was without e¡ect after Ca2 deprivation. It
was only when PKA and PKC were strongly stimulated in the
presence of high concentrations of forskolin and PMA that a
small e¡ect of glucose on insulin release (doubling at 10 mM)
was observed. In mouse islets, glucose was ine¡ective in a
Ca2-free medium with EGTA. In the absence of glucose,
pharmacological activation of PKA and PKC increased insu-
lin release to a similar extent whenever Ca2 in£ux was not
stimulated. However, increasing glucose was without e¡ect
under stringent Ca2 deprivation, similarly e¡ective up to
7 mM in the absence or presence of diazoxide and nimodi-
pine, and very e¡ective up to 30 mM only when Ca2 in£ux
was not impeded. While strong activation of the kinases is
thus able to increase insulin release in a glucose- and Ca2-
independent manner, the e¡ect of glucose can be ascribed to a
potentiation of the action of basal and elevated [Ca2]i.
Unphysiological experimental conditions are sometimes re-
quired for the identi¢cation of subtle regulatory pathways. It
is then essential to establish whether these pathways also con-
tribute to the physiological response. The second mechanism
of action of glucose, the K-ATP channel-independent, Ca2-
dependent mechanism, is most easily studied under conditions
where [Ca2]i is clamped at an elevated level (11^13). How-
ever, the ampli¢cation of the action of Ca2 by glucose can be
observed over a range of [Ca2]i spanning that of the oscil-
lations occurring in L cells stimulated by glucose in a control
medium [30]. We suggest that this pathway serves to optimize
the e⁄cacy of the increase in [Ca2]i. On the other hand, we
cannot evaluate what proportion of the secretory response to
a given glucose concentration is attributable to the rise in
[Ca2]i and to the change in Ca2 e⁄cacy.
If a Ca2-independent mechanism of regulation [24,25] is
operative only in the presence of extremely low [Ca2]i, much
lower than the concentrations ever occurring in L cells in vivo,
it is an interesting curiosity without physiological relevance. If
this mechanism is also operative in the presence of physiolog-
ical [Ca2]i, its contribution could be hidden in the overall
secretory response. Then several questions arise. First, is the
mechanism really Ca2-independent or is it similar to the
glucose-induced ampli¢cation of the action of Ca2 (second
mechanism)? This is unlikely because this Ca2-dependent
e¡ect of glucose does not require activation of PKA and
PKC [13] and persists under strong activation of these kinases
(see Fig. 1B). Second, if the mechanism is distinct from the
others, what is its quantitative importance as compared with
the Ca2-dependent mechanisms? This contribution is likely
to be minimal because, even under optimal conditions, the
amount of insulin that can be released in the absence of
Ca2 does not exceed a small percentage of the appropriate
controls. In recent experiments using capacitance measure-
ments to monitor exocytosis of insulin granules, the Ca2-
independent release induced by GTPQS was also much smaller
than that induced by Ca2 [23]. Third, could a physiological
activation of both PKA and PKC ever be su⁄cient (equiva-
lent to that produced by pharmacological agents) for the
Ca2-independent e¡ect to occur in vivo? This is most un-
likely, whereas a much milder, separate activation of each
kinase is su⁄cient to potentiate markedly Ca2-dependent
exocytosis. This has been shown by direct measurements of
insulin release from intact [31^33] or permeabilized cells
[34,35] and by capacitance measurements [19,36]. In experi-
ments using the latter approach, forskolin and PMA individ-
ually ampli¢ed the exocytotic response to Ca2 in£ux whereas
their combination had no e¡ect in the absence of depolariza-
tion-induced Ca2 rise [36].
In conclusion, although the complex sequence of events
leading to insulin secretion may include Ca2-independent
steps, the physiological regulation by glucose is essentially
achieved through the two Ca2-dependent pathways (rise in
L cell [Ca2]i and increase in Ca2 e⁄cacy), with little, if any,
contribution of a Ca2-independent mechanism.
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